Generic Topiramate for Migraine Prevention: Is Bioequivalence the Same as Therapeutic Equivalence?

Authors


  • Conflict of Interest: Dr. Evans is on the speaker's bureau of GlaxoSmithKline, Lilly, Merck, Pfizer, Teva, and UCB.

No abstract is available for this article.

Ancillary